The number of ESG regulations continues to grow. Leading medtech companies are going beyond merely complying to gain competitive advantage.
Education
- PhD, physics, Max-Planck-Society/Fritz-Haber Institute
- Diplom., physics, Humboldt University of Berlin
Jan-Frederik Jerratsch has been with Boston Consulting Group since 2011. He is a core member of the firm's Health Care practice and a specialist in life sciences, working with major high-tech, biopharma, and agribusiness clients globally.
Jan-Frederik focuses on major transformations with digitally enabled business models as well as new innovation approaches.
